ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis

ClinicalTrials.gov ID: NCT05252533

Public ClinicalTrials.gov record NCT05252533. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 6:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-label Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of Ustekinumab in Pediatric Participants

Study identification

NCT ID
NCT05252533
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
31 participants

Conditions and interventions

Interventions

  • Ustekinumab Drug

Drug

Eligibility (public fields only)

Age range
5 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 23, 2022
Primary completion
Jan 25, 2024
Completion
Jan 25, 2024
Last update posted
Apr 26, 2025

2022 – 2024

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Newport Huntington Medical Group Huntington Beach California 92648
Childrens Hospital Los Angeles Los Angeles California 90027
Northwestern University Feinberg School of Medicine Ann & Robert H Lurie Children's Hospital Chicago Illinois 60611-2991
Michigan Dermatology Institute Waterford Michigan 48328
Columbia University Medical Center New York New York 10032
Akron Children s Hospital Akron Ohio 44308
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Medical University of South Carolina Charleston South Carolina 29425
Dell Children's Medical Center of Central Texas Austin Texas 78723
Pediatric Rheumatology Consultants of Austin Austin Texas 78757

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05252533, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2025 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05252533 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →